Access Denied – Extractive Research & Development in the COVID-19 Pandemic, May 2023

This report, part of the Access Denied series, explores the role that UK public entities have played in supporting the development of COVID-19 tools such as diagnostics, vaccines and treatments. It highlights how the lack of equitable access safeguards across the research and development (R&D) continuum results in the perpetuation of an extractive global health … Continued

Access Denied: report series launch, March 2023

Three years on, the COVID-19 pandemic has officially caused the deaths of over 7 million people, disrupting livelihoods globally and continuing to have a devastating impact on communities that  don’t have widespread access to health technologies. The world’s response to the pandemic has demonstrated the flaws in the existing global system for the research, development … Continued

Featured Access Denied: What happens when Big Pharma is in the driver’s seat, January 2023

STOPAIDS and Global Health Advocates’ report series ‘Access Denied‘ explores how a lack of transparency in the pharmaceutical industry and the EU has harmed public health outcomes. The series is structured into two reports. The first set the scene through speaking to key actors and stakeholders who were involved in or following the contract negotiations. In … Continued